Buscar
Mostrando ítems 41-50 de 426
O papel da histocompatibilidade em transplantes de células-tronco hematopoiéticas: revisão da literatura
(Universidade Federal do Rio Grande do NorteBrasilUFRNBiomedicina, 2016-12-12)
Through the studies about transplants in liquid tissues, such as the bone marrow, the need for histocompatibility between donor and recipient was realized. Compatibility occurs through equivalence in human leukocyte antigens ...
Análise da mobilização, coleta e infusão de células-tronco hematopoiéticas do sangue periférico para transplante autogênico no Hospital Universitário de Santa Maria
(Universidade Federal de Santa MariaBRAnálises Clínicas e ToxicológicasUFSMPrograma de Pós-Graduação em Ciências Farmacêuticas, 2013-01-23)
The transplantation of hematopoietic peripheral blood stem cells is one of the
therapeutic choices for the treatment of various hematological and oncological diseases,
extending disease-free survival and, in some cases, ...
O transplante alogênico de células-tronco hematopoéticas no tratamento do Mieloma MúltiploAllogeneic hematopoietic stem cell transplant for Multiple Myeloma
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2007)
PTK2 and PTPN11 expression in myelodysplastic syndromes
(Hospital Clinicas, Univ Sao PauloSao PauloBrasil, 2013)
Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation
(Oxford University Press, 2020)
Background. Bacteremia and other invasive bacterial infections are common among children with cancer receiving intensive chemotherapy and in pediatric recipients of hematopoietic stem cell transplantation (HSCT). Systemic ...
Ehrlich ascites tumor as a tool in the development of compounds with immunomodulatory properties
(Marcel Dekker IncNew YorkEUA, 2004)
Non-hematopoietic PAR-2 is essential for matriptase-driven pre-malignant progression and potentiation of ras-mediated squamous cell carcinogenesis
(Nature Publishing Group, 2015-01-15)
The membrane-anchored serine protease, matriptase, is consistently dysregulated in a range of human carcinomas, and high matriptase activity correlates with poor prognosis. Furthermore, matriptase is unique among ...